Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 146 participants.
Also called NCT03527069
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 146 participants
- Sponsor
- EMS
- Registry
-
NCT03527069
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Brazil
- Registry status
- Completed
Technical summary
Registry record NCT03527069. Randomized; double masking; primary purpose treatment. Start 2021-01-29 (actual); primary completion 2024-08-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment
- Condition
- Hypertriglyceridemia
- Condition
- Dyslipidemia
- Intervention (Drug)
- Cipros 10 association
- Intervention (Drug)
- Crestor 10 mg
- Lead sponsor
- EMS
Record details
- Record id
cardio:ct-nct03527069- Content hash
0f57a632f30c80fb8ab9a5bd913ce0f88154caaed78d837b603c636eaaa18bde